UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

FORM 8-K

Current Report Filed Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report
(Date of earliest event reported): March 30, 2005

Zonagen, Inc.

2408 Timberloch Place, Suite B-1
The Woodlands, Texas 77380
(Address of principal executive offices and zip code)
(281) 719-3400
(Registrant’s telephone number, including area code)

 

Item 7.01 Regulation FD Disclosure

     Zonagen, Inc. (the “Company”) announced in a press release dated March 30, 2005 its financial results for the three months and year ended December 31, 2004. A copy of the Company’s press release is attached hereto as Exhibit 99.1. The press release is incorporated by reference herein and the foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.

     The information in this report, including each of the Exhibits, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. In addition, the information in this report, including the Exhibit, shall not be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

     c. Exhibits

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Zonagen, Inc.
Date: March 30, 2005.	By:	/s/ Joseph S. Podolski
		Joseph S. Podolski
		President and Chief Executive Officer

 

EXHIBIT INDEX